Internal Medicine, Medical Oncology · Ann Arbor, MI
NPI
1710982533
Since 2005
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
24 Frank Lloyd Wright Drive, Suite J2000
Ann Arbor, MI, 48105
Phone (734) 747-6766
Groups this clinician bills Medicare through
Medicare paid, 2024
$78K
1,247 services
Medicare patients, 2024
330
Average age 74
Drug cost, 2024
$6.0M
1,808 prescriptions
Company payments, 2025
$134
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher Reynolds was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 412 times for 223 patients. In total Christopher Reynolds billed 1,247 services in 19 codes, and Medicare paid $78K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-12-19.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 412 | 223 | $12.57 | $5,181 |
| 99214 Office E&M - Established | Office | 371 | 198 | $91.98 | $34K |
| 99215 Office E&M - Established | Office | 123 | 75 | $132.07 | $16K |
| 99213 Office E&M - Established | Office | 79 | 65 | $60.11 | $4,749 |
| 36415 Venipuncture Blood Collection | Office | 72 | 16 | $8.65 | $623 |
| M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 38 | 13 | $68.60 | $2,607 |
| 99204 Office E&M - New | Office | 35 | 35 | $117.78 | $4,122 |
| 99223 Hospital E&M - Initial | Facility | 30 | 30 | $138.18 | $4,145 |
| 99233 Hospital E&M - Subsequent | Facility | 21 | 14 | $94.64 | $1,987 |
By year: 2022 $111K for 1,004 services; 2023 $84K for 947 services; 2024 $78K for 1,247 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 72 | 16 | $8.65 | $623 |
Medicare prescription drug claims, 2024
In 2024, the drug Christopher Reynolds prescribed most often to Medicare patients was Anastrozole, with 220 prescriptions and refills. In total Christopher Reynolds wrote 1,808 Medicare prescriptions that cost $6.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 220 | 598 | 74 | $11K |
| Tamoxifen Citrate Generic | 121 | 299 | 40 | $4,239 |
| Hydroxyurea Generic | 94 | 203 | 20 | $3,906 |
| Acyclovir Generic | 85 | 139 | 18 | $2,003 |
| Dexamethasone Generic | 85 | 123 | 35 | $1,338 |
| Revlimid Lenalidomide | 82 | 82 | 15 | $1.0M |
| Prednisone Generic | 80 | 120 | 22 | $342 |
| Prochlorperazine Maleate Generic | 78 | 78 | 53 | $1,627 |
| Letrozole Generic | 75 | 211 | 25 | $6,316 |
| Abiraterone Acetate Generic | 66 | 66 | 11 | $92K |
| Jakafi Ruxolitinib Phosphate | 58 | 58 | Under 11 | $934K |
| Imbruvica Ibrutinib | 54 | 54 | Under 11 | $864K |
| Eliquis Apixaban | 53 | 73 | 13 | $41K |
| Ibrance Palbociclib | 44 | 44 | Under 11 | $670K |
| Anagrelide Hcl Generic | 28 | 36 | Under 11 | $3,103 |
Brand drugs: 458 claims; generic drugs: 1,350 claims; opioid claims: 84.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher Reynolds $134 ($134 in general payments such as food, travel and fees) from 6 companies. The largest payer was Tempus AI, Inc with $111.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.